Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2027

Study Completion Date

August 1, 2027

Conditions
ObesityType 2 Diabetes
Interventions
PROCEDURE

Bariatric surgery + goal directed medical therapy

Patients will undergo bariatric surgery (RYGB or SG) with goal directed medical therapy titrated to specific end points for BP, HbA1c and lipids

PROCEDURE

Bariatric surgery

Patients will undergo bariatric surgery (RYGB or SG) with usual care for diabetes mellitus undertaken by their primary care provider/general practitioner

Trial Locations (1)

Unknown

RECRUITING

University College Dublin, Dublin

All Listed Sponsors
lead

Imperial College London

OTHER